For more than 30 years, the Service of Pharmacology and Immunoanalysis (SPI) of the CEA's Frédéric Joliot Institute offers its expertise in the development of immunoanalytical methods, physicochemical analyzes (LC-MS), genetic detection ( PCR) and cell culture allowing it to address the detection, quantification and fate of potentially dangerous molecules or microorganisms. Since 2005, his research in the field of biosafety has been supported by the interdepartmental R&D program NRBC-E, entrusted by public authorities to the CEA.